Development, Standardisation and Standardisation Project for a New Memory Assessment

Recruiting now

Conditions studied: Memory Disorders

In brief

Episodic memory (EM) is a neuropsychological marker of Alzheimer's disease (AD) (Thomas-Anterion, 2006). Current tests for its assessment do not take into account the identity and emotional aspects of memory (Van der Linden et al., 2018). However, there are models that integrate links with identity, self-awareness and experience. Pause et al. (2013) propose criteria to create ecological tools, including consideration of the emotional valence of memories and the spatio-temporal context of acquisition. In line with these criteria, we have developed a new tool: the NEM (New evaluation of Episodic Memory). Preliminary studies show different response profiles on the NEM among patients (Launay et al., 2023). We now want to evaluate the relevance of this tool in the differential diagnosis of AD.

Key facts

Study ID

NCT06564779

Run by

University Hospital, Tours

People needed

150

Starts

2024-11-22

Expected to finish

2028-11-01

Last updated by the study team

2026-04-30

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 50 years
• Ability to understand judged sufficient by the assessor;
• Amnesic MCI profile (Petersen, 2003) during the 1st medical consultation prior to the assessment being prescribed.

You may not qualify if…

• Severe auditory and/or visual sensory impairment not compatible with neuropsychological assessment;
• Judged fit to take the test by the assessor;
• Patient under guardianship, curatorship or family guardianship;
• Opposition to data processing.

Where it is running

• University hospital — Tours, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.